Cleveland Clinic Vasculitis Advances and Controversies 2025

• Target Audience: rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians
• Sample video: contact me for sample video
• Information:

This comprehensive course dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. Participants will critically appraise emergent treatment options for small vessel vasculitis and large vessel vasculitis. In-depth evaluations will explore the central nervous system involvement in vasculitis and the current and future landscape of glucocorticoid use in vasculitis management.

By the end of this course, participants will be equipped with the knowledge to effectively evaluate and implement cutting-edge treatments and diagnostic strategies in their practice.

Who Should Attend?

The Symposium is directed towards rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, nurse practitioners, nurses, and physician assistants interested in the treatment of vasculitis.

After completing this course, participants will be able to:

Critically appraise emergent treatment options in small vessel vasculitis and large vessel vasculitis

Evaluate CNS involvement in vasculitis

Evaluate current and future landscape of glucocorticoid use in vasculitis management

Discuss imaging advancement in large vessel vasculitis and other diagnostic modalities in vasculitis

Appraise the diagnostic modalities in giant cell arteritis

Appraise the role of plasma exchange in ANCA-associated vasculitis

• Topics:

1 Emergent treatment in small vessel vasculitis.pdf

1 Emerging treatment in small vessel vasculitis.mp4

2 Emergent treatment in large vessel vasculitis.mp4

2 Emergent treatment in large vessel vasculitis.pdf

3 EGPA – What can I offer to my patients.pdf

4 Question & Answer.mp4

5 Central Nervous System involvement in vasculitis.mp4

5 Central Nervous System involvement in vasculitis.pdf

6 Ask the Masters Challenging cases in vasculitis.mp4

6 Ask the Masters Challenging cases in vasculitis.pdf

7 Glucocorticoid use in small vessel vasculitis.mp4

7 Glucocorticoid use in small vessel vasculitis.pdf

8 Glucocorticoid use in large vessel vasculitis.mp4

8 Glucocorticoid use in large vessel vasculitis.pdf

9 Question & Answer.mp4

10 Large vessel vasculitis imaging.mp4

10 Large vessel vasculitis imaging.pdf

11 Kidney pathology in small vessel vasculitis.mp4

11 Kidney pathology in small vessel vasculitis.pdf

12 Pathology in large vessel vasculitis.mp4

12 Pathology in large vessel vasculitis.pdf

13 Eye exam in giant cell arteritis.mp4

13 Eye exam in giant cell arteritis.pdf

14 Question & Answer.mp4

15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.mp4

15 Biopsy or imaging in the diagnosis of giant cell arteritis Tanaz Kermani, MD.pdf

16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.mp4

16 Biopsy or imaging in the diagnosis of giant cell arteritis Kinanah Yaseen, MD.pdf

17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.mp4

17 Does plasma exchange have a role in ANCA associated vasculitis Ali Mehdi, MD.pdf

18 Does plasma exchange have a role in ANCA associated vasculitis Alexandra Villa-Forte, MD.pdf

19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.mp4

19 Should Tocilizumab be used in every patient with giant cell arteritis Adam Brown, MD.pdf

20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.mp4

20 Should Tocilizumab be used in every patient with giant cell arteritis Michael Putman, MD.pdf

21 Question & Answer.mp4

Agenda.pdf

May 8, 2025.mp4